Advanced search
Start date

Establishment and standardization of the humanization process of the anti-IL-7R therapeutic antibody by the CDR-grafting technique

Grant number: 23/11129-6
Support Opportunities:Scholarships in Brazil - Doctorate (Direct)
Effective date (Start): September 01, 2023
Effective date (End): January 31, 2028
Field of knowledge:Biological Sciences - Immunology - Applied Immunology
Principal Investigator:Priscila Pini Zenatti Salles
Grantee:Joey Ramone Ferreira Fonseca
Host Institution: Centro Infantil de Investigações Hematológicas Dr Domingos A Boldrini (CIB). Campinas , SP, Brazil
Associated research grant:21/04137-7 - Monoclonal antibodies against pediatric Acute Lymphoblastic Leukemia, AP.JP


Acute lymphoblastic leukemia (ALL) is a type of malignant hematological neoplasm, frequent in children and characterized by overproduction of blasts in the bone marrow and extramedullary regions. Somatic mutations in exon 6 of the IL-7Ra gene are related to the leukemogenesis process and are expressed in approximately 9% of patients with T-ALL. Anti-IL7R murine monoclonal antibodies, called hIL7R#55 and hIL7R#69 (hereinafter, mAb#55 and mAb#69, respectively) obtained in our research group, from the hybridoma technology, recognize the IL7 receptor both in its wild-type (WT) conformation, as a mutant and show therapeutic potential against ALL, both in vitro and in vivo in PDX models. However, these 100% murine antibodies can lead to the development of a disease called HAMA (human anti-murine antibodies) in approximately 50 to 80% of patients after a single dose of treatment. The antibody humanization process reduces the murine portions of the antibody sequence to 3% and, consequently, makes it less immunogenic. The humanization process called antibody CDR-Grafting basically consists of transplanting the 3 CDRs sequences (Complementarity Determining Region) of the murine antibody to sequences of a framework of a human antibody. For this project, we propose to establish and standardize the humanization process of two murine antibody clones with therapeutic potential against pediatric ALL. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Please report errors in scientific publications list using this form.